Detalhe da pesquisa
1.
Acceptance and feasibility of a low-threshold and substitution services-based periodical monitoring system for blood-borne and sexually transmitted infections among people who inject drugs in Germany: a mixed-methods analysis.
Harm Reduct J
; 21(1): 62, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38486197
2.
International harm reduction indicators are still not reached: results from a repeated cross-sectional study on drug paraphernalia distribution in Germany, 2021.
Harm Reduct J
; 20(1): 137, 2023 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37726726
3.
[Hepatitis B virus infection and vaccine-induced immunity: the role of sociodemographic determinants : Results of the study "German Health Interview and Examination Survey for Adults" (DEGS1, 2008-2011)]. / Hepatitis-B-Virus-Infektionen und impfinduzierte Immunität: die Rolle von soziodemografischen Determinanten : Ergebnisse der "Studie zur Gesundheit Erwachsener in Deutschland" (DEGS1, 20082011).
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 65(2): 159-169, 2022 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-34958395
4.
[Epidemiology of viral hepatitis A to E in Germany]. / Epidemiologie der Virushepatitiden A bis E in Deutschland.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 65(2): 149-158, 2022 Feb.
Artigo
em Alemão
| MEDLINE | ID: mdl-35029725
5.
Hepatitis B vaccination coverage in Germany: systematic review.
BMC Infect Dis
; 21(1): 817, 2021 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34391406
6.
Univariable associations between a history of incarceration and HIV and HCV prevalence among people who inject drugs across 17 countries in Europe 2006 to 2020 - is the precautionary principle applicable?
Euro Surveill
; 26(49)2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34886941
7.
[How to assess the elimination of viral hepatitis B, C, and D in Germany? Outcomes of an interdisciplinary workshop]. / Wie lässt sich die Eliminierung von Hepatitis B, C und D in Deutschland messen? Ergebnisse eines interdisziplinären Arbeitstreffens.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 64(1): 77-90, 2021 Jan.
Artigo
em Alemão
| MEDLINE | ID: mdl-33326051
8.
High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011-2014: missed opportunities for hepatitis C testing.
Harm Reduct J
; 17(1): 7, 2020 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31924208
9.
[How well is the screening of pregnant women for HIV, syphilis, and hepatitis B implemented in Germany? An analysis based on routine data]. / Gelingt das Screening von Schwangeren auf HIV, Syphilis und Hepatitis B in Deutschland? Eine Analyse auf Basis von Routinedaten.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
; 63(9): 1143-1150, 2020 Sep.
Artigo
em Alemão
| MEDLINE | ID: mdl-32840637
10.
Comment on "Population-based screening works: Effect of integrating screening for hepatitis B and C into the general health check-up in Germany".
J Hepatol
; 81(1): e28-e29, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38403028
11.
Dating apps and websites as tools to reach anonymous sexual contacts during an outbreak of hepatitis A among men who have sex with men, Berlin, 2017.
Euro Surveill
; 24(21)2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31138363
12.
Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe.
J Hepatol
; 68(3): 402-411, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29080808
13.
Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010-2015.
J Hepatol
; 67(1): 15-22, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28189752
14.
Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014.
BMC Infect Dis
; 17(1): 484, 2017 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28693564
15.
High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in Germany.
BMC Public Health
; 17(1): 843, 2017 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29065873
16.
High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
BMC Public Health
; 16: 927, 2016 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27595567
17.
Conversation about Serostatus decreases risk of acquiring HIV: results from a case control study comparing MSM with recent HIV infection and HIV negative controls.
BMC Public Health
; 14: 453, 2014 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24885694
18.
A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling.
BMC Public Health
; 14: 845, 2014 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25124485
19.
Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis.
Lancet Reg Health Eur
; 36: 100792, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38188273
20.
Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots--performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification.
Virol J
; 10: 72, 2013 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23497102